NZ223005A - Nasal solutions for administering calcitonin - Google Patents

Nasal solutions for administering calcitonin

Info

Publication number
NZ223005A
NZ223005A NZ223005A NZ22300587A NZ223005A NZ 223005 A NZ223005 A NZ 223005A NZ 223005 A NZ223005 A NZ 223005A NZ 22300587 A NZ22300587 A NZ 22300587A NZ 223005 A NZ223005 A NZ 223005A
Authority
NZ
New Zealand
Prior art keywords
nasal solutions
pharmaceutical compositions
calcitonin
human calcitonin
administering calcitonin
Prior art date
Application number
NZ223005A
Inventor
Leo Geller
Rudolf Wackernagel-Strasse
Peter Glanzmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ223005A publication Critical patent/NZ223005A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Abstract

Pharmaceutical compositions in the form of aqueous solutions for the nasal administration of human calcitonin in meterable amounts, a process for the production of these pharmaceutical compositions and their use are described. The pharmaceutical composition contains a) a therapeutically effective amount of human calcitonin or a derivative thereof, b) viscosity-increasing swelling agents and c) an aqueous vehicle optionally containing isotonic additives and/or additional auxiliaries.
NZ223005A 1986-12-23 1987-12-21 Nasal solutions for administering calcitonin NZ223005A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH520086 1986-12-23

Publications (1)

Publication Number Publication Date
NZ223005A true NZ223005A (en) 1990-07-26

Family

ID=4289609

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ223005A NZ223005A (en) 1986-12-23 1987-12-21 Nasal solutions for administering calcitonin

Country Status (15)

Country Link
EP (1) EP0277462B1 (en)
JP (1) JPS63166832A (en)
AT (1) ATE75404T1 (en)
AU (1) AU608268B2 (en)
CA (1) CA1322330C (en)
DE (1) DE3778682D1 (en)
DK (1) DK166714B1 (en)
ES (1) ES2032303T3 (en)
GR (1) GR3004585T3 (en)
IL (1) IL84861A (en)
MY (1) MY102411A (en)
NZ (1) NZ223005A (en)
PH (1) PH24802A (en)
PT (1) PT86436B (en)
ZA (1) ZA879593B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
AU638128B2 (en) * 1990-04-10 1993-06-17 University Of Melbourne, The Calcitonin gene related peptide for the treatment of undescended testicles
WO1991015246A1 (en) * 1990-04-10 1991-10-17 The University Of Melbourne Calcitonin gene related peptide for the treatment of undescended testicles
JP3179538B2 (en) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト Aqueous solution of stable human calcitonin
GB9108634D0 (en) * 1991-04-23 1991-06-12 Ciba Geigy Pharmaceutical compositions
WO1995033474A1 (en) * 1994-06-03 1995-12-14 Tsumura & Co. Medicinal composition
ES2180274T3 (en) * 1998-01-30 2003-02-01 Novartis Consumer Health Sa NASAL DISSOLUTIONS.
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
JP2002154989A (en) * 2000-11-14 2002-05-28 Lion Corp Ophthalmic composition and composition having improved retention of medicine in biological mucosa
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
CH657858A5 (en) * 1983-06-27 1986-09-30 Ciba Geigy Ag SUBSTANCE FROM THE CALCITONINE GROUP.
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
DE3500268A1 (en) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt PREPARATIONS WITH DELAYED EFFECT, METHOD FOR THE PRODUCTION THEREOF AND CORRESPONDING AGENTS FOR THE HUMAN OR. VETERINE MEDICAL APPLICATION
JPS61194034A (en) * 1985-02-25 1986-08-28 Teijin Ltd Powdery composition for transnasal administration

Also Published As

Publication number Publication date
AU8295587A (en) 1988-06-23
AU608268B2 (en) 1991-03-28
ZA879593B (en) 1988-06-22
EP0277462A1 (en) 1988-08-10
PT86436A (en) 1988-01-01
JPS63166832A (en) 1988-07-11
DE3778682D1 (en) 1992-06-04
MY102411A (en) 1992-06-17
CA1322330C (en) 1993-09-21
ES2032303T3 (en) 1993-02-01
ATE75404T1 (en) 1992-05-15
EP0277462B1 (en) 1992-04-29
DK676987A (en) 1988-06-24
IL84861A (en) 1992-09-06
DK676987D0 (en) 1987-12-22
DK166714B1 (en) 1993-07-05
GR3004585T3 (en) 1993-04-28
PH24802A (en) 1990-10-30
PT86436B (en) 1990-11-20

Similar Documents

Publication Publication Date Title
EP0552256A4 (en)
GR1001503B (en) Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses.
MY101026A (en) An improved method for administering insulin.
MX171191B (en) PHARMACEUTICAL COMPOSITIONS OF GLIPIZIDE
AU7880991A (en) A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
NL990012I1 (en) Medicines containing salmeterol and fluticasone.
NZ223005A (en) Nasal solutions for administering calcitonin
MY101784A (en) Novel pharmacological compounds
NZ219374A (en) Topical pharmaceutical containing tamoxifen
HUT41644A (en) Process for producing therapeutic preparation suitable for transdermic treating
ES8702427A1 (en) 2-Substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them.
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
GR3002765T3 (en) New pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
KR880004810A (en) Peptic Ulcer Treatment
IT8722647A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
DK277387A (en) THERAPEUTIC TOPICAL COMPOSITION AGAINST A HYPERPROLIFIING EPITHAL DISEASE
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ATE36957T1 (en) N,N-DIETHYL-5-METHYL-2H,1-BENZOTHIOPYRANO-(4,3,-CD)-INDAZOLE-2-ETHANAMINE, THE PREPARATIONS CONTAINING THEM AND THEIR USE.
IL76458A0 (en) Polyether ionophore,its preparation and pharmaceutical and veterinary preparations containing it
ES2029161A6 (en) Process for the preparation of zinc carbocysteinate compositions and their use in hepatopathies.
JO1531B1 (en) Novel pharmacological compounds
IT8819541A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.